α-fetoprotein levels after interferon therapy and risk of hepatocarcinogenesis in chronic hepatitis C
Hepatology2013Vol. 58(4), pp. 1253–1262
Citations Over TimeTop 1% of 2013 papers
Yasuhiro Asahina, Kaoru Tsuchiya, Takashi Nishimura, Masaru Muraoka, Yuichiro Suzuki, Nobuharu Tamaki, Yutaka Yasui, Takanori Hosokawa, Ken Ueda, Hiroyuki Nakanishi, Jun Itakura, Yuka Takahashi, Masayuki Kurosaki, Nobuyuki Enomoto, Mina Nakagawa, Sei Kakinuma, Mamoru Watanabe, Namiki Izumi
Abstract
Post-IFN treatment ALT and AFP levels are significantly associated with hepatocarcinogenesis. Measurement of these values is useful for predicting future HCC risk after IFN treatment. Suppression of these values after IFN therapy reduces HCC risk even in patients without HCV eradication.
Related Papers
- → Fluorescence spectroscopy to diagnose hepatic steatosis in a rat model of fatty liver(2009)19 cited
- → Rapid Decrease in Liver Graft Steatosis in the Early Post-transplant Period: A Blinded and Randomized Study(2019)3 cited
- → Regression of Graft Steatosis After Liver Transplantation(2022)1 cited
- [Steatosis in chronic viral hepatitis C: frequency, risk factors and relationship with fibrosis].(2008)
- Analysis of the influence factors of serum alpha-fetoprotein levels in patients with hepatocellular carcinoma(2001)